Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Experimental | 2 | 2021 | 195 | 1.160 |
Why?
|
| Pre-Eclampsia | 8 | 2021 | 202 | 1.130 |
Why?
|
| Diabetic Retinopathy | 4 | 2020 | 110 | 0.860 |
Why?
|
| Anesthesia | 1 | 2021 | 120 | 0.730 |
Why?
|
| Diabetes Mellitus, Type 1 | 7 | 2020 | 529 | 0.690 |
Why?
|
| Pregnancy in Diabetics | 5 | 2020 | 70 | 0.640 |
Why?
|
| Pregnancy Trimester, First | 3 | 2020 | 43 | 0.350 |
Why?
|
| Valine | 2 | 2018 | 43 | 0.320 |
Why?
|
| Taurine | 2 | 2018 | 51 | 0.310 |
Why?
|
| Lipoproteins, LDL | 5 | 2020 | 343 | 0.310 |
Why?
|
| Vitamin D | 2 | 2020 | 516 | 0.270 |
Why?
|
| Pericytes | 2 | 2016 | 81 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2021 | 24 | 0.230 |
Why?
|
| Oxidative Stress | 3 | 2016 | 718 | 0.220 |
Why?
|
| Pregnancy | 8 | 2021 | 2334 | 0.220 |
Why?
|
| Medetomidine | 1 | 2021 | 6 | 0.210 |
Why?
|
| Xylazine | 1 | 2021 | 5 | 0.210 |
Why?
|
| Adrenergic Agents | 1 | 2021 | 14 | 0.210 |
Why?
|
| Lipoproteins | 2 | 2021 | 161 | 0.210 |
Why?
|
| Pentobarbital | 1 | 2021 | 19 | 0.200 |
Why?
|
| Prodrugs | 2 | 2018 | 54 | 0.190 |
Why?
|
| Blood-Retinal Barrier | 1 | 2020 | 15 | 0.190 |
Why?
|
| Fenofibrate | 1 | 2020 | 23 | 0.190 |
Why?
|
| Hypolipidemic Agents | 1 | 2020 | 82 | 0.180 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2020 | 58 | 0.180 |
Why?
|
| Haptoglobins | 1 | 2019 | 12 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2021 | 2083 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 214 | 0.170 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2020 | 145 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 215 | 0.160 |
Why?
|
| Adipokines | 1 | 2017 | 20 | 0.150 |
Why?
|
| Autophagy | 2 | 2016 | 208 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 191 | 0.140 |
Why?
|
| Albuminuria | 1 | 2017 | 171 | 0.140 |
Why?
|
| Ependymoglial Cells | 1 | 2016 | 7 | 0.140 |
Why?
|
| Berberine | 1 | 2016 | 3 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 700 | 0.140 |
Why?
|
| Alzheimer Disease | 2 | 2018 | 565 | 0.140 |
Why?
|
| Rats | 2 | 2021 | 5300 | 0.140 |
Why?
|
| Electroretinography | 1 | 2016 | 122 | 0.130 |
Why?
|
| Peptide Fragments | 1 | 2018 | 483 | 0.130 |
Why?
|
| Retina | 2 | 2016 | 252 | 0.130 |
Why?
|
| Cholesterol, HDL | 1 | 2015 | 112 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2017 | 307 | 0.120 |
Why?
|
| Zinc | 1 | 2015 | 73 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 694 | 0.120 |
Why?
|
| Animals | 4 | 2021 | 20880 | 0.120 |
Why?
|
| Antioxidants | 1 | 2016 | 304 | 0.120 |
Why?
|
| Copper | 1 | 2015 | 149 | 0.110 |
Why?
|
| Capillaries | 1 | 2014 | 105 | 0.110 |
Why?
|
| Antigen-Antibody Complex | 1 | 2014 | 175 | 0.110 |
Why?
|
| Humans | 15 | 2021 | 68549 | 0.110 |
Why?
|
| Biomarkers | 4 | 2020 | 1593 | 0.100 |
Why?
|
| Young Adult | 5 | 2020 | 5710 | 0.090 |
Why?
|
| Male | 4 | 2021 | 37283 | 0.090 |
Why?
|
| Placenta | 2 | 2021 | 101 | 0.090 |
Why?
|
| Female | 10 | 2021 | 38021 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2020 | 2673 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 2791 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2550 | 0.080 |
Why?
|
| Cell Survival | 3 | 2016 | 901 | 0.080 |
Why?
|
| Adult | 7 | 2020 | 21379 | 0.080 |
Why?
|
| Norway | 2 | 2019 | 18 | 0.080 |
Why?
|
| Mice | 2 | 2016 | 8474 | 0.070 |
Why?
|
| Australia | 2 | 2019 | 235 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2017 | 3703 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1085 | 0.060 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2016 | 99 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1054 | 0.060 |
Why?
|
| Apoptosis | 3 | 2016 | 1641 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2016 | 499 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 2356 | 0.050 |
Why?
|
| Trophoblasts | 1 | 2021 | 29 | 0.050 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2020 | 10 | 0.050 |
Why?
|
| Dextrans | 1 | 2020 | 33 | 0.050 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2020 | 58 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2020 | 251 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2020 | 131 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 157 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2018 | 31 | 0.040 |
Why?
|
| Drug Administration Routes | 1 | 2018 | 25 | 0.040 |
Why?
|
| Propionates | 1 | 2018 | 21 | 0.040 |
Why?
|
| Nonlinear Dynamics | 1 | 2018 | 55 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 120 | 0.040 |
Why?
|
| Tablets | 1 | 2018 | 19 | 0.040 |
Why?
|
| Capsules | 1 | 2018 | 18 | 0.040 |
Why?
|
| Half-Life | 1 | 2018 | 96 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 139 | 0.040 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2017 | 9 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 770 | 0.040 |
Why?
|
| Lipocalin-2 | 1 | 2017 | 19 | 0.040 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2017 | 12 | 0.040 |
Why?
|
| Resistin | 1 | 2017 | 9 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2017 | 30 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 292 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 238 | 0.040 |
Why?
|
| Adiponectin | 1 | 2017 | 52 | 0.040 |
Why?
|
| Models, Chemical | 1 | 2018 | 155 | 0.040 |
Why?
|
| Leptin | 1 | 2017 | 80 | 0.040 |
Why?
|
| Creatinine | 1 | 2017 | 243 | 0.040 |
Why?
|
| Aged | 3 | 2018 | 14842 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2018 | 411 | 0.040 |
Why?
|
| Beclin-1 | 1 | 2016 | 11 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2016 | 24 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 274 | 0.040 |
Why?
|
| Transcription Factor CHOP | 1 | 2016 | 28 | 0.030 |
Why?
|
| Adenine | 1 | 2016 | 46 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 946 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2016 | 71 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 75 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 201 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 209 | 0.030 |
Why?
|
| Glycation End Products, Advanced | 1 | 2016 | 125 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2018 | 342 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 247 | 0.030 |
Why?
|
| Eye Proteins | 1 | 2016 | 160 | 0.030 |
Why?
|
| United States | 2 | 2019 | 7338 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 567 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2015 | 73 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 706 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 122 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2016 | 330 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 2093 | 0.030 |
Why?
|
| Receptors, Scavenger | 1 | 2014 | 13 | 0.030 |
Why?
|
| Serpins | 1 | 2016 | 205 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 42 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 866 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1745 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1738 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 563 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1040 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1174 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 626 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 280 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2014 | 94 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 4655 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2018 | 1449 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 481 | 0.020 |
Why?
|
| Middle Aged | 2 | 2018 | 21119 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 866 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5720 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 2265 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 2176 | 0.020 |
Why?
|